Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only
Open Access
- 1 February 2002
- Vol. 87 (2) , 97-98
- https://doi.org/10.1136/heart.87.2.97
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese populationHeart, 2002
- Left ventricular dysfunction, natriuretic peptides, and mortality in an urban populationHeart, 2001
- HEART FAILURE: The diagnosis of heart failureHeart, 2000
- Impact of Diabetes on Cardiac Structure and FunctionCirculation, 2000
- Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential HypertensionCirculation, 1998
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Brain natriuretic peptide predicts mortality in the elderly.Heart, 1997
- Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?Heart, 1993
- Brain natriuretic peptide as a cardiac hormone in essential hypertensionThe American Journal of Medicine, 1992